Biotech

All Articles

Ideaya bags alternative on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is wagering $400 thousand in biobucks that a bispecific antibody-drug conjugate ...

Takeda takes $140M reduction on neglected epilepsy medication, touts FDA run

.Our team already know that Takeda is expecting to find a path to the FDA for epilepsy medicine soti...

VBI Vaccinations declare bankruptcy, finds possession purchase

.Immunology biotech VBI Vaccines is actually drifting dangerously near to the defining moment, along...

Celldex anti-cKIT antitoxin decrease hives in an additional stage 2 study

.It's hard to muscular tissue in on a room as reasonable as immunology, but Celldex Rehabs strongly ...

Boehringer offers up to $1.3 B for checkpoint prevention biotech

.Boehringer Ingelheim is actually providing to $1.3 billion for Nerio Therapeutics as well as a prec...

Ventyx's last resort for inflammatory med ends in Crohn's failure

.Ventyx Biosciences' Crohn's illness medication carried out not aid people accomplish remission in a...

Cognition's phase 2 beam information taint Alzheimer's prospect

.Knowledge Therapies' phase 2 sparkle test has actually taken a few of the luster off the Alzheimer'...

BMS axes bispecific months after filing to work stage 3 trial

.Bristol Myers Squibb has actually possessed a whiplash change of heart on its BCMA bispecific T-cel...

Charles Baum manages Terremoto as CEO

.Charles Baum, M.D., Ph.D., who supervised Mirati Therapies' $ 5.8 billion purchase to Bristol Myers...

Asarina to close after initiatives to companion Tourette's medication stop working

.After reaching out to much more than 200 business to companion a Tourette disorder therapy that sho...